What is pelvic inflammatory disease (PID)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 18, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Pelvic Inflammatory Disease (PID)

Pelvic inflammatory disease is an infection-caused inflammatory condition of the female upper genital tract, including any combination of endometritis, salpingitis, tubo-ovarian abscess, and pelvic peritonitis, primarily resulting from ascending spread of microorganisms from the vagina and endocervix. 1

Etiology

PID has a polymicrobial etiology involving multiple organisms:

  • Primary sexually transmitted pathogens:

    • Neisseria gonorrhoeae (cervical isolation rates 27-80%)
    • Chlamydia trachomatis (cervical isolation rates 5-39%)
    • Mycoplasma genitalium
  • Secondary microorganisms (found in 25-50% of cases):

    • Anaerobes: Bacteroides, Peptostreptococcus, Peptococcus species
    • Facultative bacteria: Gardnerella vaginalis, Streptococcus species, Escherichia coli, Haemophilus influenzae
    • Other: Mycoplasmas, bacterial vaginosis-associated organisms 1, 2

Pathogenesis

PID develops through:

  1. Direct canalicular spread of organisms from the endocervix to the endometrium and fallopian tubes
  2. Noncanalicular spread via parametrial lymphatics (less common)

Contributing factors to ascending infection:

  • Uterine instrumentation (e.g., IUD insertion)
  • Hormonal changes during menses (reduced cervical barrier function)
  • Retrograde menstruation
  • Organism-specific virulence factors 1

Clinical Presentation

PID presents with a wide spectrum of symptoms, making diagnosis challenging:

  • Common symptoms: Lower abdominal pain, abnormal vaginal discharge
  • Additional symptoms: Metrorrhagia, postcoital bleeding, urinary frequency, fever
  • Important note: Many women (particularly those with chlamydial PID) may have subtle, mild, or even no symptoms 3, 2

Diagnosis

The clinical diagnosis of PID is imprecise, with a positive predictive value of 65-90% compared to laparoscopy. Due to the risk of serious sequelae, a low threshold for diagnosis is recommended 1.

Minimum criteria for clinical diagnosis:

  • Lower abdominal tenderness
  • Bilateral adnexal tenderness
  • Cervical motion tenderness 1

Additional supportive criteria:

  • Routine criteria:

    • Oral temperature >38.3°C (101°F)
    • Abnormal cervical/vaginal discharge
    • Elevated WBCs on vaginal secretion microscopy
    • Elevated ESR or C-reactive protein
    • Laboratory documentation of cervical infection with N. gonorrhoeae or C. trachomatis 1
  • Elaborate criteria (for severe cases):

    • Histopathologic evidence of endometritis
    • Tubo-ovarian abscess on imaging
    • Laparoscopic findings consistent with PID 1

Treatment

Early administration of appropriate antibiotics is crucial to reduce the risk of long-term sequelae 3. Treatment should provide broad-spectrum coverage against likely pathogens.

Outpatient treatment (mild-to-moderate PID):

  • Extended-spectrum cephalosporin PLUS either doxycycline or azithromycin 4, 2
  • Patients should show substantial improvement within 72 hours; if not, reevaluation, hospitalization, and parenteral therapy are indicated 1

Inpatient treatment (severe PID):

  • Indications for hospitalization:

    • Severe symptoms
    • Tubo-ovarian abscess
    • Pregnancy
    • Inability to tolerate oral medications
    • Failure to respond to oral therapy 1
  • Parenteral broad-spectrum antibiotics with activity against polymicrobial flora, particularly gram-negative aerobes and anaerobes 4, 2

  • May switch to oral therapy 24 hours after clinical improvement, completing a total of 14 days of treatment 1

Partner Management

  • Male sex partners should be examined and treated if they had sexual contact with the patient during the 60 days before symptom onset
  • This is critical due to the risk of reinfection and the high likelihood of urethral gonococcal or chlamydial infection in partners 1

Complications and Sequelae

PID can lead to serious long-term consequences:

  • Infertility (tubal factor)
  • Ectopic pregnancy
  • Chronic pelvic pain
  • Recurrent PID
  • Tubo-ovarian abscess 5, 6

Prevention

  • Regular screening for chlamydial and gonococcal infections in sexually active women
  • Prompt treatment of cervicitis and bacterial vaginosis
  • Consistent condom use
  • Reduction in number of sexual partners 1

Key Points for Clinicians

  • Maintain a low threshold for diagnosis due to the potential for serious sequelae
  • Begin treatment promptly when PID is suspected
  • Consider PID in sexually active women with pelvic or lower abdominal pain, even with mild symptoms
  • Remember that many cases of PID may be asymptomatic or present with subtle symptoms
  • Ensure appropriate partner treatment to prevent reinfection

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Pelvic inflammatory disease.

Obstetrics and gynecology, 2010

Research

Pelvic inflammatory disease (PID) from Chlamydia trachomatis versus PID from Neisseria gonorrhea: from clinical suspicion to therapy.

Giornale italiano di dermatologia e venereologia : organo ufficiale, Societa italiana di dermatologia e sifilografia, 2012

Research

Pelvic inflammatory disease and its sequelae in adolescents.

Journal of adolescent health care : official publication of the Society for Adolescent Medicine, 1985

Research

Diagnosis and treatment of pelvic inflammatory disease.

Women's health (London, England), 2008

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.